Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Dec 26;22(1):1148.
doi: 10.1186/s12967-024-05974-2.

Epidemiological and clinical characteristics of ammonia-producing microorganisms in the lungs of patients with severe pneumonia: a multicentre cohort study

Jun Xu #  1 , Xindie Ren #  1 , Xiaohan Huang #  1 , Yue Jin #  2 , Mingqiang Wang  2 , Lin Zhong  3 , Guojun He  1 , Shengfeng Wang  4 , Qianqian Wang  5 , Muhua Dai  6 , Yonghui Xiong  7 , Yinghe Xu  8 , Xuwei He  9 , Yujie Pan  10 , Hongyu Wang  11 , Qi Xia  12 , Huanzhang Shao  13 , Lingtong Huang  14 , Hongliu Cai  15
Affiliations
Multicenter Study

Epidemiological and clinical characteristics of ammonia-producing microorganisms in the lungs of patients with severe pneumonia: a multicentre cohort study

Jun Xu et al. J Transl Med. .

Abstract

Background: Ureaplasma urealyticum, Ureaplasma parvum, and Mycoplasma hominis were widely known as ammonia-producing microorganisms and can cause hyperammonemia, leading to cerebral edema and altered consciousness, which represent serious complications in lung transplant recipients. However, there is limited knowledge on the epidemiology and outcomes of infections caused by U. urealyticum, U. parvum, and M. hominis in non-transplant patients with severe pneumonia in the ICU.

Methods: Patients with severe pneumonia who underwent clinical metagenomics of bronchoalveolar lavage fluid (BALF) at the intensive care units (ICUs) of 17 medical centers from January 2019 to March 2023 were enrolled. All cases were divided into the positive group and the negative group based on whether U. urealyticum, U. parvum, or M. hominis was detected in lower respiratory tract. The clinical characteristics and outcomes were compared among the groups. The survival analysis after propensity score matching (PSM) was used to evaluate whether the mortality rate of U. urealyticum, U. parvum, and M. hominis positive patients were increased. Multivariate logistic regression was used to evaluate whether these microbials positivity were a risk factor for central nervous system dysfunction.

Results: In a total number of 1737 patients, 55 patients (3.17%) in the positive group and 1682 patients (96.83%) in the negative group. Patients in the positive group were younger, had a greater proportion of male patients, and had a longer time from ICU admission to clinical metagenomics testing. In contrast, the negative group had a higher proportion of patients with cerebrovascular disease. After PSM, there was no statistically significant difference in 28-day mortality following ICU admission between the two groups (hazard ratio [HR], 0.842; 95% confidence interval [CI], 0.489-1.451; p = 0.536). Multivariate logistic regression analysis showed an association between the detection of U. urealyticum, U. parvum, or M. hominis and neurological dysfunction (odds ratio [OR], 1.84; 95% CI 1.04-3.24; p = 0.035).

Conclusion: The detection of U. urealyticum, U. parvum, or M. hominis in the lungs of patients is associated with neurological dysfunction.

Keywords: Mycoplasma hominis; Ureaplasma parvum; Ureaplasma urealyticum; Hyperammonemia; Neurological dysfunction; Severe pneumonia.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study has been approved by the ethics committees of the first affiliated hospital, Zhejiang university school of medicine and other participating hospitals. As a retrospective study, informed consent was waived. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of the patients
Fig. 2
Fig. 2
Multivariate logistic regression analysis of risk factors for neurological dysfunction. OR odds ratio, CI confidence interval, CVD cerebrovascular disease, CAP community-acquired pneumonia, HAP hospital acquired pneumonia, VAP ventilator-associated pneumonia, IMV invasive mechanical ventilation, NIV non-invasive ventilation
Fig. 3
Fig. 3
Kaplan–Meier survival curves of patients in the positive group (pale green) and in the negative group (pink). ICU intensive care unit, LOS length of stay, CI confidence interval
See this image and copyright information in PMC

References

    1. Sakusic A, Rabinstein AA. Acute coma. Neurol Clin. 2021;39:257–72. - PubMed
    1. Edlow JA, Rabinstein A, Traub SJ, Wijdicks EFM. Diagnosis of reversible causes of coma. Lancet. 2014;384:2064–76. - PubMed
    1. Watson AJ, Chambers T, Karp JE, Risch VR, Walker WG, Brusilow SW. Transient idiopathic hyperammonaemia in adults. Lancet. 1985;2:1271–4. - PubMed
    1. Buzo BF, Preiksaitis JK, Halloran K, Nagendran J, Townsend DR, Zelyas N, et al. Association between mycoplasma and ureaplasma airway positivity, ammonia levels, and outcomes post-lung transplantation: a prospective surveillance study. Am J Transpl. 2021;21:2123–31. - PubMed
    1. Wylam ME, Kennedy CC, Hernandez NM, Peters SG, Maleszewski JJ, Cassivi SD, et al. Fatal hyperammonaemia caused by mycoplasma hominis. Lancet. 2013;382:1956. - PubMed

Publication types

LinkOut - more resources